Huahui Yi
Publications
ClueTracer: Question-to-Vision Clue Tracing for Training-Free Hallucination Suppression in Multimodal Reasoning
Large multimodal reasoning models solve challenging visual problems via explicit long-chain inference: they gather visual clues from images and decode clues into textual tokens. Yet this capability also increases hallucinations, where the model generates content that is not supported by the input image or the question. To understand this failure mode, we identify \emph{reasoning drift}: during clue gathering, the model over-focuses on question-irrelevant entities, diluting focus on task-relevant cues and gradually decoupling the reasoning trace from visual grounding. As a consequence, many inference-time localization or intervention methods developed for non-reasoning models fail to pinpoint the true clues in reasoning settings. Motivated by these insights, we introduce ClueRecall, a metric for assessing visual clue retrieval, and present ClueTracer, a training-free, parameter-free, and architecture-agnostic plugin for hallucination suppression. ClueTracer starts from the question and traces how key clues propagate along the model's reasoning pathway (question $\rightarrow$ outputs $\rightarrow$ visual tokens), thereby localizing task-relevant patches while suppressing spurious attention to irrelevant regions. Remarkably, \textbf{without any additional training}, ClueTracer improves all \textbf{reasoning} architectures (including \texttt{R1-OneVision}, \texttt{Ocean-R1}, \texttt{MM-Eureka}, \emph{etc}.) by $\mathbf{1.21\times}$ on reasoning benchmarks. When transferred to \textbf{non-reasoning} settings, it yields a $\mathbf{1.14\times}$ gain.
RareAlert: Aligning heterogeneous large language model reasoning for early rare disease risk screening
Missed and delayed diagnosis remains a major challenge in rare disease care. At the initial clinical encounters, physicians assess rare disease risk using only limited information under high uncertainty. When high-risk patients are not recognised at this stage, targeted diagnostic testing is often not initiated, resulting in missed diagnosis. Existing primary care triage processes are structurally insufficient to reliably identify patients with rare diseases at initial clinical presentation and universal screening is needed to reduce diagnostic delay. Here we present RareAlert, an early screening system which predict patient-level rare disease risk from routinely available primary-visit information. RareAlert integrates reasoning generated by ten LLMs, calibrates and weights these signals using machine learning, and distils the aligned reasoning into a single locally deployable model. To develop and evaluate RareAlert, we curated RareBench, a real-world dataset of 158,666 cases covering 33 Orphanet disease categories and more than 7,000 rare conditions, including both rare and non-rare presentations. The results showed that rare disease identification can be reconceptualised as a universal uncertainty resolution process applied to the general patient population. On an independent test set, RareAlert, a Qwen3-4B based model trained with calibrated reasoning signals, achieved an AUC of 0.917, outperforming the best machine learning ensemble and all evaluated LLMs, including GPT-5, DeepSeek-R1, Claude-3.7-Sonnet, o3-mini, Gemini-2.5-Pro, and Qwen3-235B. These findings demonstrate the diversity in LLM medical reasoning and the effectiveness of aligning such reasoning in highly uncertain clinical tasks. By incorporating calibrated reasoning into a single model, RareAlert enables accurate, privacy-preserving, and scalable rare disease risk screening suitable for large-scale local deployment.